Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Please select


For My Business

< R10m annual turnover

For My Business

> R10m annual turnover

Switch to FNB Business

Product shop

By Turnover

First Business Zero (R0 - R5 million p.a) Gold Business (R0 - R5 million p.a) Platinum Business (R5 million - R60 million p.a) Enterprise Business (R60 million - R150 million+ p.a)

Transact

Business Accounts Credit Cards Cash Solutions Merchant Services eWallet Pro Staffing Solutions ATM Solutions Ways to bank Fleet Services Guarantees

Savings and Investments

Save and Invest 3PIM (3rd Party Investment Manager)

Borrow

FNB Cash Advance Overdraft Loans Debtor Finance Leveraged Finance Private Equity Securities Based Lending Selective Invoice Discounting Asset Based Finance Alternative Energy Solutions Commercial Property Finance Fleet Services

Insure

Insurance

For my employees

Staffing Solutions Employee benefits

Forex + Trade

Foreign Exchange Imports and exports Structured Trade + Commodity Finance Business Global Account (CFC account)

Value Adds + Rewards

Connect my business the dti initiatives Enterprise and supplier development Business Hub eBucks Rewards for Business DocTrail™ CIPC Integration Channel Instant Accounting Solutions Instant Payroll Instant Cashflow Instant Invoicing SLOW 24/7 Business Desk FNB Business Fundaba nav» Marketplace Prepaid products Accounting integrations

Industry Expertise

Philanthropy Chinese Business Islamic Banking Agriculture Public Sector Education Healthcare Franchise Motor Dealership Tourism

Going Global

Global Commercial Banking

Financial Planning

Overview

Bank Better

KYC / FICA Debit order + recipient switching Electronic Alerts

Corporates + Public Sector

Corporate Public Sector

All savings + investment accounts


Cash deposits

Notice deposits Immediate access Access to a portion Fixed deposits

Share investing

Shares

Tax-free investing

Tax-free accounts

Funds/unit trusts

Ashburton specialised products

Invest abroad

Offshore products

I want to save for

Personal goals Child's education Emergencies Tax-free

Compare similar

Compare

Additional options

Show me all Help me chosse Find an advisor

Financial planning

Overview

Back

Trade Ideas

Local Trade Idea: Clicks Group (CLS) - BUY

 

Clicks Group is a health and beauty focused retail and supply group. The group has hundreds of stores across southern Africa through its market-leading retail brands, Clicks and The Body Shop. United Pharmaceutical Distributors (UPD) provides distribution capability for the group's healthcare strategy and has close to a third of market share in private pharmaceutical wholesale in South Africa.

Clicks is a defensive company and is characterised by growth, high return on equity (ROE), strong cash conversion and execution.

Technically, the share price is displaying a confluence of both the 200-day and the 200-week simple moving averages, with a bias toward the upside (refer to the first chart). This is a strong indicator of the price trend and suggests that bullish sentiment will improve significantly.

The share is trading above the 200-day simple moving average (SMA) of ~R262. A further uptick in the price will confirm the strong bullish trend.

Fading downside price momentum according to the MACD indicator, and sidewards movement of the On-Balance Volume indicator (which suggests money is flowing into the share) support our bullish stance.

The share is also testing its 61.8% Fibonacci retracement level, which is another positive sign.

Share Information

Share Code CLS
Industry Food and Drug Retailers
Market Capital (ZAR) 65.13 billion
One Year Total Return -12.38%
Return Year-to-Date 3.05%
Current Price (ZAR) 271.71
52 Week High (ZAR) 318.44
52 Week Low (ZAR) 232.63
Financial Year End August
Closing paragraph The share price has come under a bit of pressure since last year, but various technical indicators suggest a strong improvement going forward.

Consensus expectations

(Bloomberg)

FY22 FY23E FY24E FY25E
Headline Earnings per Share (ZAR) 10.45 11.69 12.97 14.23
Growth (%) 11.82 11.01 9.67
Dividend Per Share (ZAR) 6.79 7.55 8.36 9.22
Growth (%) 11.13 10.77 10.28
Forward PE (times) 22.90 20.61 19.14
Forward Dividend Yield (%) 2.83 3.13 3.39
Closing paragraph Earnings growth is expected to remain robust over the medium term.

Buy/Sell Rationale

Technical Analysis:

  • On the second chart we see the relative strength index (RSI) backcross signals, denoted by a reading of 1. These signals occur when there is a crossover in the share price above the oversold-territory threshold. In essence, downside momentum in the share has faded, and there is strong potential for a reversal to the upside. This is considered a bullish signal.
  • Our entry range is between R255 and R274 - a drop below this level may indicate a structural change in the trend, giving reason to negate the trade idea.
  • Our target price is R311, representing upside of ~15% from current levels.
  • Forward calculations of the RSI suggest that the stock will be in overbought territory at R350, making our profit target realistic.
  • Our proposed time to exit is mid-January 2023, though investors can adjust for either a longer or shorter time horizon, depending on price behaviour.
  • A drop below R246 (downside of ~9% from current levels) would imply weakening technicals. As such, a stop-loss is recommended at this level.
  • We suggest a low capital at-risk allocation for this trade. Increase portfolio exposure for a break above R274.

Long-term fundamental view:

  • Clicks has proven to be an excellent competitor in the retail and distribution space. The company is led by a strong management team, which has improved various operational efficiencies, lowered costs, reduced excess investment in working capital and enhanced product availability. In addition, the company has a high return of equity, minimal debt and is highly cash generative.
  • The group reported a decent set of results for FY23, with adjusted HEPS and revenue growing 11.5% and 5.1%, respectively. Growth in the retail business was particularly impressive, with market share gains being recorded across all product categories. This was supported by robust growth in private label sales, as well as a sustained recovery in the personal care and beauty category.
  • Although the outlook statement was cautious (with management mindful of a constrained economic environment), the growth strategy is still positive considering the strong pipeline of new store openings. Management's confidence in the business model is also encouraging.
  • Clicks' business mix is considered defensive in nature, meaning that the company performs relatively well in times of economic downturns or market volatility. This is particularly attractive given current macro-economic conditions.
  • Key risks to our fundamental view include regulatory intervention within the pharmaceutical sector. Increased competition from food retailers introducing pharmacy offerings continues to pose a risk.

Share Name and position BVT - Stop Loss
(Close the Position)
INL - Time Exit
(Close the Position)
DCP - Buy
(Continue to hold)
Entry 272.78 105.00 24.12
Current 257.77 99.63 23.78
Movement -5.5% -5.1% -1.4%
Summary text The share price breached our stop-loss level, and thus we closed the position. Weakening technicals indicate limited support for a recovery in the share price. Given that we have reached our intended time-exit, we suggest closing the position. The share continues to display signs of bullish divergence. The price remains below its 200-day simple moving average, and we maintain the counter-trend strategy. The price action also seems to be building a base.

Our profit target is R29, with a trailing stop-loss at R22. Close the position around 29 December 2023.

Share Name and position STXRES - Buy
(Continue to hold)
ANG - Buy
(Continue to hold)
APN - Buy
(Continue to hold)
Entry 59.63 369.83 182.66
Current 57.95 357.04 167.02
Movement -2.8% -3.5% -8.6%
Summary text The ETF is trading at major support in an accumulation phase and remains below the 200-day simple moving average. Upside price momentum is fading and is a concern.

Our profit target is R69, with a trailing stop-loss at R56. Exit the trade around 8 January 2024.
Price action is at the early stage of a change in trend, and this remains of interest. The share remains below the 200-day simple moving average. Upside momentum has halted.

Our profit target is R459, with a trailing stop-loss at R342. Exit the trade around 22 January 2023.
The formation of a symmetrical triangle pattern in the share price remains attractive. The share, however, is trading below its 200-day simple moving average, with downside price momentum still a concern.

Our profit target is R222, with a trailing stop-loss at R160. Exit the trade around 27 December 2023.

How would you like to log in?